The Site's participation in three clinical trials of drugs for the treatment of ulcerative colitis was approved by the sponsor of the study - the pharmaceutical company Pfizer.
The Site's participation in three clinical trials of drugs for the treatment of ulcerative colitis was approved by the sponsor of the study - the pharmaceutical company Pfizer.
